Health In Tech, Inc.
HIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -8.16 | 0.76 | -0.04 | 3.63 |
| FCF Yield | 1.26% | 1.17% | -0.49% | -0.39% |
| EV / EBITDA | 211.78 | 42.07 | 35.07 | 11,181.66 |
| Quality | ||||
| ROIC | 2.11% | 3.25% | 2.39% | -2.31% |
| Gross Margin | 60.59% | 67.75% | 66.82% | 77.43% |
| Cash Conversion Ratio | 1.49 | 2.35 | 1.06 | 3.68 |
| Growth | ||||
| Revenue 3-Year CAGR | 30.15% | 45.33% | 75.25% | 2,691,087.82% |
| Free Cash Flow Growth | 300.32% | 424.42% | 84.51% | -155.38% |
| Safety | ||||
| Net Debt / EBITDA | -9.61 | -8.22 | -9.00 | -302.86 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -65.28 | -80.02 | -116.90 | -111.70 |